Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frank E. Thomas currently holds 55,150 shares of Orchard Therapeutics plc (ORTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank E. Thomas has been a net seller of ORTX stock. They have purchased $98.8K and sold $2.6M worth of shares.
Frank E. Thomas's most recent insider trade was on May 19, 2026, when they sold 55,150 shares at $0.00 per share.
Frank E. Thomas serves as Executive at Orchard Therapeutics plc (ORTX). They have executed 64 insider transactions totaling $2.7M over their tenure at the company.
Frank E. Thomas holds the position of Executive at Orchard Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Frank E. Thomas has shown a selling trading pattern, with $98.8K in total purchases and $2.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Frank E. Thomas was on Aug 5, 2015, when they sold $1.0M worth of AMAG shares. This transaction involved 15,000 shares at $66.85 per share.
Frank E. Thomas currently owns 55,150 shares of Orchard Therapeutics plc (ORTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frank E. Thomas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frank E. Thomas has 64 Form 4 filings on record as an insider at Orchard Therapeutics plc.
Set alerts for Frank E. Thomas and 40,000+ other insiders.